New video for World Scleroderma Day 2018 World Scleroderma Day 2018 I attended the 5th Systemic Sclerosis World Congress FDA grants Fast Track designation to nintedanib for the treatment of systemic sclerosis with associated interstitial lung disease Phase 2 clinical study for patients with diffuse cutaneous systemic sclerosis (dcSSc) or patients with pulmonary arterial hypertension (PAH)